These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1766836)

  • 1. Anti-phospholipid auto-antibodies and thrombosis.
    Freyssinet JM; Grunebaum L; Goetz J; Wiesel ML
    Nouv Rev Fr Hematol (1978); 1991; 33(2):111-3. PubMed ID: 1766836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiphospholipid antibodies: specificity and mechanism of action].
    Tobelem G
    Ann Med Interne (Paris); 1990; 141(3):257-60. PubMed ID: 2114812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-phospholipid antibodies.
    Harris EN; Gharavi AE; Hughes GR
    Clin Rheum Dis; 1985 Dec; 11(3):591-609. PubMed ID: 3935364
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells.
    Patterson AM; Ford I; Graham A; Booth NA; Greaves M
    Br J Haematol; 2006 May; 133(3):323-30. PubMed ID: 16643435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
    Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
    Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times.
    Zhao Y; Rumold R; Zhu M; Zhou D; Ahmed AE; Le DT; Hahn BH; Woods VL; Chen PP
    Arthritis Rheum; 1999 Oct; 42(10):2132-8. PubMed ID: 10524684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis.
    Freyssinet JM; Cazenave JP
    Thromb Haemost; 1987 Aug; 58(2):679-81. PubMed ID: 3118497
    [No Abstract]   [Full Text] [Related]  

  • 8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of anti-phospholipid antibodies].
    Shimmyozu K; Okadome T; Maruyama Y; Kadokura N; Maruyama I; Osame M; Tara M
    Rinsho Ketsueki; 1990 May; 31(5):633-8. PubMed ID: 2118574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor.
    Salemink I; Blezer R; Willems GM; Galli M; Bevers E; Lindhout T
    Thromb Haemost; 2000 Oct; 84(4):653-6. PubMed ID: 11057865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of anti-phospholipid antibodies in the development of thrombotic complications and in obstetrical pathology].
    Prudnikova LZ; Alekberova ZS; Nasonov EL; Side'lnikova VM; Manuĭlova LP
    Klin Med (Mosk); 1989 Jun; 67(6):59-64. PubMed ID: 2779156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid antibody syndrome: description of a case].
    Todaro G; Lo Vecchio L; Trovato GM; Mazzone O
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):307-10. PubMed ID: 2640052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid antibodies: physiopathology and clinical aspects].
    Todesco S
    G Clin Med; 1990 Nov; 71(11):627-30, 633-7. PubMed ID: 2128285
    [No Abstract]   [Full Text] [Related]  

  • 15. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
    Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
    J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lupus anticoagulant in neurology.
    el-Mallakh RS
    Bull Clin Neurosci; 1986; 51():102-7. PubMed ID: 3137986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiphospholipid antibodies, thrombosis and lupus disease. Value of the assay of anticardiolipin antibodies by the ELISA technic].
    Meyer O; Cyna L; Borda-Iriarte O; Jungers P; Piette JC; Dautzenberg MD; Dupuy E; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1985 May; 52(5):297-305. PubMed ID: 3874416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-way interactions between inflammation and coagulation.
    Levi M; van der Poll T
    Trends Cardiovasc Med; 2005 Oct; 15(7):254-9. PubMed ID: 16226680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculopathy associated with the antiphospholipid antibody syndrome.
    Bowles CA
    Rheum Dis Clin North Am; 1990 May; 16(2):471-90. PubMed ID: 2189163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible mechanisms of action of the antiphospholipid binding antibodies.
    Khamashta MA; Asherson RA; Hughes GR
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S85-9. PubMed ID: 2557994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.